Safety of i.v. administration of redback spider antivenom

Internal Medicine Journal

Volumn 37, Issue 12, 2007, Pages 820-822

  Isbister, G K ^a,b,c  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^c NEWCASTLE MATER HOSPITAL   (Australia)

Author keywords

Adverse reaction; Allergy; Antivenom; Envenoming; Latrodectism; Redback spider

Indexed keywords

ADRENALIN; HYDROCORTISONE; PROMETHAZINE; SPIDER VENOM ANTISERUM;

ADULT; ARTICLE; CONTROLLED STUDY; COUGHING; DIAPHORESIS; DRUG SAFETY; DYSPHAGIA; ERYTHEMA; FACE EDEMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PRIORITY JOURNAL; SERUM SICKNESS; SKIN PRURITUS; SOCIAL WELFARE; STATISTICAL ANALYSIS;

ADULT; ANIMALS; ANTIVENINS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPIDER VENOMS; TREATMENT OUTCOME;

EID: 36348943990     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01513.x     Document Type: Article

References (15)

1. Wiener S. Redback spider bite in Australia: an analysis of 167 cases. Med J Aust 1961 2 : 44 9.
2. Isbister GK, Graudins A, White J, Warrell D. Antivenom treatment in arachnidism. J Toxicol Clin Toxicol 2003 41 : 291 300.
3. Ho J, White J, Staples A, Hobbs P. An Analysis of Antivenom Use in Australia, Based on Reports of Use, 1995-2000. Proceedings of XIIIth World Congress of the International Society of Toxinology September 2000 P202.
4. Isbister GK. Failure of intramuscular antivenom in redback spider envenomation. Emerg Med 2002 14 : 436 9.
5. Clark RF. The safety and efficacy of antivenin Latrodectus mactans. J Toxicol Clin Toxicol 2001 39 : 125 7.
6. Krifi MN, Amri F, Kharrat H, El Ayeb M. Evaluation of antivenom therapy in children severely envenomed by Androctonus australis garzonii (Aag) and Buthus occitanus tunetanus (Bot) scorpions. Toxicon 1999 37 : 1627 34.
7. Riviere G, Choumet V, Audebert F, Sabouraud A, Debray M, Scherrmann JM et al. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy. J Pharmacol Exp Ther 1997 281 : 1 8.
8. Wiener S. Latrodectism: a prospective cohort study of bites by formally identified redback spiders. Med J Aust 2003 179 : 455 6.
9. Sutherland SK, Trinca JC. Survey of 2144 cases of red-back spider bites: Australia and New Zealand, 1963-1976. Med J Aust 1978 2 : 620 23.
10. Sutherland SK. Serum reactions. An analysis of commercial antivenoms and the possible role of anticomplementary activity in de-novo reactions to antivenoms and antitoxins. Med J Aust 1977 1 : 613 15.
11. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004 114 : 371 6.
12. Ellis RM, Sprivulis PC, Jelinek GA, Banham ND, Wood SV, Wilkes GJ et al. A double-blind, randomized trial of intravenous versus intramuscular antivenom for Red-back spider envenoming. Emerg Med Australas 2005 17 : 152 6.
13. Graudins A, Dowsett RP, Vassiliadis J. Red-back spider (Latrodectus mactans hasselti) envenomation requiring "High-dose" antivenom therapy. J Toxicol Clin Toxicol 1999 37 : 615.
14. Isbister GK, Gray MR. Effects of envenoming by comb-footed spiders of the genera Steatoda and Achaearanea (family Theridiidae: Araneae) in Australia. J Toxicol Clin Toxicol 2003 41 : 809 19.
15. Byrne GC, Pemberton PJ. Red-back spider (Latrodectus mactans hasselti) envenomation in a neonate. Med J Aust 1983 2 : 665 6.